losartan has been researched along with preminent in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (6.67) | 29.6817 |
| 2010's | 28 (93.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malliani, A; Montano, N | 1 |
| Bubnova, MG; Oganov, RG | 1 |
| Balink, H; de Graaf, W; Grond, J; Hemmelder, MH | 1 |
| Inoue, A; Kuwano, T; Mitsutake, R; Miura, S; Morii, J; Saku, K; Shiga, Y; Uehara, Y | 1 |
| Akaba, K; Endo, S; Fukui, A; Gomi, H; Hamaguchi, A; Hanaoka, K; Hara, Y; Hasegawa, T; Hayakawa, H; Hayashi, F; Hikida, M; Hirano, K; Horiguchi, M; Hosoya, M; Hosoya, T; Ichida, K; Ikeda, M; Imai, T; Ishii, T; Ishikawa, H; Ishikawa, M; Kameda, C; Kanai, T; Kasai, T; Kawamura, T; Kobayashi, A; Kobayashi, H; Kurashige, M; Kuriyama, S; Kusama, Y; Maezawa, H; Maezawa, Y; Maruyama, Y; Matsuda, H; Matsuo, N; Matsuo, T; Miura, Y; Miyajima, M; Miyakawa, M; Miyazaki, Y; Mizuguchi, M; Morita, T; Nakao, M; Nokano, H; Ogura, M; Ohkido, I; Ohno, I; Ohtsuka, Y; Okada, K; Okamoto, H; Okonogi, H; Saikawa, H; Saito, H; Sekiguchi, C; Soejima, M; Suetsugu, Y; Sugano, N; Suzuki, T; Takahashi, H; Takahashi, Y; Takamizawa, S; Takane, K; Takazoe, K; Tanaka, H; Tanaka, S; Terawaki, H; Tokudome, G; Tomonari, H; Toyoshima, R; Tsuboi, N; Udagawa, T; Ueda, H; Ueda, Y; Uetake, M; Unemura, S; Utsunomiya, M; Utsunomiya, Y; Yamada, T; Yamada, Y; Yamaguchi, Y; Yamamoto, H; Yokoo, T; Yokoyama, K; Yonezawa, H; Yoshida, H; Yoshida, M; Yoshizawa, T | 1 |
| Aoun, J; Girerd, X; Rosenbaum, D | 1 |
| Arima, H; Fujii, K; Fukuhara, M; Kato, I; Kawasaki, J; Matsumura, K; Morinaga, Y; Ohta, Y; Ohtsubo, T; Otonari, T; Sasaguri, T; Tominaga, M; Tsuchihashi, T; Uezono, K | 2 |
| Ayabe, T; Eto, T; Etoh, T; Ichiki, Y; Kato, J; Kita, T; Kitamura, K; Tamaki, N; Yokota, N | 1 |
| Eguchi, K; Fukutomi, M; Hoshide, S; Kabutoya, T; Kario, K; Watanabe, T | 1 |
| Fujiwara, K; Shimada, Y; Suzuki, H | 1 |
| Hanayama, Y; Makino, H; Nakamura, Y; Uchida, HA | 1 |
| Eguchi, K; Fukutomi, M; Hoshide, S; Kario, K; Watanabe, T | 1 |
| Cornelissen, G; Halberg, F; Otsuka, K; Watanabe, Y | 1 |
| Hamada, T; Haruaki, N; Hirota, Y; Hisatome, I; Kato, M; Kosaka, H; Kotake, H; Kuwabara, M; Miyazaki, S; Mizuta, E; Nakamura, H; Ogino, K; Ohtahara, A; Omodani, H; Taniguchi, S; Watanabe, A; Watanabe, M; Yamamoto, K | 1 |
| Dobrokhod, AS; Kushnir, SM; Radchenko, GD; Sirenko, YM; Torbas, OO | 1 |
| Asakura, J; Hasegawa, H; Iwashita, T; Kawashima, K; Matsuda, A; Mitarai, T; Nakamura, T; Ogawa, T; Shimizu, T; Takayanagi, K; Tayama, Y | 1 |
| Jain, R; Khuroo, A; Kumar, S; Kurachi, K; Monif, T; Reyar, S; Singla, AK | 1 |
| O'Prinsen, AC; Pechlivanoglou, P; Postma, MJ; Schuiling-Veninga, N; Stevanović, J; Verheggen, BG | 1 |
| Mori, H; Nishida, K; Okada, Y; Tanaka, Y; Uriu, K; Yamamoto, S | 1 |
| Fujisaki, K; Higashi, H; Hirakata, H; Kanai, H; Katafuchi, R; Kitazono, T; Nakano, T; Nakayama, M; Taniguchi, M; Tsuruya, K | 1 |
| Asayama, K; Elnagar, N; Hosaka, M; Imai, Y; Kojima, I; Metoki, H; Miyawaki, Y; Obara, T; Ohkubo, T; Satoh, M | 1 |
| Fujiwara, K; Shimada, K; Suzuki, H | 1 |
| Anegawa, T; Aoki, Y; Fukuda, K; Fukumoto, Y; Imaizumi, T; Iwamoto, Y; Kai, H; Uchiwa, H; Ueda, T | 1 |
| Arias, SC; Fanelli, C; Fujihara, CK; Malheiros, DM; Souza, RA; Zatz, R | 1 |
| Duran-Salgado, MB; Elizalde-Barrera, CI; Garro-Almendaro, AK; Rubio-Guerra, AF; Suarez-Cuenca, JA | 1 |
| Matsushima, T; Nakajima, H; Nakajima, K; Ohko, K; Sano, S | 1 |
| Anegawa, T; Fukuda, K; Fukumoto, Y; Imaizumi, T; Iwamoto, Y; Kai, H; Kajimoto, H; Uchiwa, H | 1 |
| Abe, J; Fukuda, A; Hasegawa, S; Hatahira, H; Ishiguro, M; Kanoh, H; Kinosada, Y; Motooka, Y; Naganuma, M; Nakamura, M; Nakao, S; Sasaoka, S; Seishima, M; Ueda, N | 1 |
| Ahn, YK; Chae, SC; Cho, EJ; Cho, MC; Choi, DJ; Chung, WJ; Ha, JW; Hong, SJ; Hong, TJ; Kim, CJ; Kim, SK; Kim, YJ; Lee, HY; Park, CG; Park, S; Shin, J; Sohn, IS; Sung, KC; Yoo, BS; Youn, HJ | 1 |
15 trial(s) available for losartan and preminent
| Article | Year |
|---|---|
Efficacy and safety of early versus late titration of fixed-dose irbesartan/hydrochlorothiazide: ACTUAL study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies | 2011 |
Does a combination pill of antihypertensive drugs improve medication adherence in Japanese? A randomized controlled trial.
Topics: Administration, Oral; Aged; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Blood Pressure; Chi-Square Distribution; Diuretics; Drug Combinations; Female; Health Knowledge, Attitudes, Practice; Humans; Hydrochlorothiazide; Hypertension; Japan; Linear Models; Losartan; Male; Medication Adherence; Middle Aged; Tablets; Time Factors; Treatment Outcome | 2012 |
Three-year safety and effectiveness of fixed-dose losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension under clinical setting (PALM-1 Extension Study).
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Asian People; Blood Pressure; Diuretics; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome | 2012 |
Change in high-sensitive cardiac troponin T on hypertensive treatment.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Troponin T | 2013 |
Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2012 |
Low-grade inflammation and ambulatory blood pressure response to antihypertensive treatment: the ALPHABET study.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Inflammation; Losartan; Male; Middle Aged; Treatment Outcome | 2013 |
A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension.
Topics: Adult; Aged; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Uric Acid | 2014 |
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bisoprolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chi-Square Distribution; Diuretics; Doxazosin; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Pulse Wave Analysis; Severity of Illness Index; Time Factors; Treatment Outcome; Ukraine; Vascular Stiffness | 2013 |
Pharmacokinetic comparison and bioequivalence evaluation of losartan/ hydrochlorothiazide tablet between Asian Indian and Japanese volunteers.
Topics: Adolescent; Adult; Asian People; Biological Availability; Cross-Over Studies; Drug Combinations; Female; Healthy Volunteers; Humans; Hydrochlorothiazide; India; Losartan; Male; Middle Aged; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency | 2014 |
Type 2 diabetes mellitus complicated by hypertension in Japanese patients: switching treatment from high-dose angiotensin II receptor blockers to losartan plus hydrochlorothiazide.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Drug Substitution; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Japan; Losartan; Male; Middle Aged; Treatment Outcome | 2014 |
Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension.
Topics: Adult; Aged; Creatinine; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Treatment Outcome; Uric Acid; Young Adult | 2014 |
Differential effects of angiotensin II receptor blocker and losartan/hydrochlorothiazide combination on central blood pressure and augmentation index.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome; Young Adult | 2015 |
Benefit of losartan/hydrochlorothiazide-fixed dose combination treatment for isolated morning hypertension: The MAPPY study.
Topics: Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Prospective Studies; Treatment Outcome | 2015 |
Effect of losartan combined with amlodipine or with a thiazide on uric acid levels in hypertensive patients.
Topics: Amlodipine; Antihypertensive Agents; Biomarkers; Blood Pressure; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Time Factors; Treatment Outcome; Uric Acid | 2017 |
Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Republic of Korea; Time Factors; Treatment Outcome | 2019 |
15 other study(ies) available for losartan and preminent
| Article | Year |
|---|---|
Antihypertensive treatment and sympathetic excitation.
Topics: Antihypertensive Agents; Baroreflex; Blood Pressure; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Losartan; Muscle, Skeletal; Sympathetic Nervous System | 2005 |
[Treatment of patients with arterial hypertension and other stroke risk factors in clinical practice. The PROGNOS program].
Topics: Aged; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Risk Factors; Stroke | 2009 |
Scintigraphic diagnosis of Erdheim-Chester disease.
Topics: Aged; Amlodipine; Antihypertensive Agents; Diabetes Mellitus, Type 2; Drug Combinations; Erdheim-Chester Disease; Gated Blood-Pool Imaging; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Hypolipidemic Agents; Imidazoles; Knee Joint; Losartan; Male; Metformin; Positron-Emission Tomography; Prostatic Neoplasms; Simvastatin | 2011 |
Comparison of the efficacy and safety of single-pill fixed-dose combinations of losartan/hydrochlorothiazide and valsartan/hydrochlorothiazide in patients with hypertension (SALT-VAT study).
Topics: Aged; Blood Pressure; Drug Combinations; Drug Substitution; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
Antihypertensive effect of a fixed-dose combination of losartan/hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Creatinine; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Hyperuricemia; Japan; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Treatment Outcome; Uric Acid; Young Adult | 2012 |
Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
Topics: Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Comorbidity; Databases, Factual; Diabetes Mellitus; Diuretics; Drug Combinations; Drug Prescriptions; Female; Guideline Adherence; Humans; Hydrochlorothiazide; Hypertension; Japan; Losartan; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prevalence; Renal Insufficiency, Chronic; Retrospective Studies; Sex Factors; Time Factors; Treatment Outcome | 2012 |
Toward a personalized chronotherapy of high blood pressure and a circadian overswing.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Drug Chronotherapy; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Models, Cardiovascular; Precision Medicine | 2013 |
Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Losartan; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Prospective Studies; Treatment Outcome | 2013 |
Release from glomerular overload by the addition of low-dose thiazide in patients with angiotensin receptor blocker-resistant hypertension.
Topics: Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Dose-Response Relationship, Drug; Drug Combinations; Essential Hypertension; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney Glomerulus; Losartan; Male; Middle Aged; Prospective Studies | 2013 |
Economic evaluation of primary prevention of cardiovascular diseases in mild hypertension: a scenario analysis for the Netherlands.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Markov Chains; Middle Aged; Netherlands; Primary Prevention; Risk Factors; Smoking | 2014 |
Antihypertensive effectiveness of combination therapy with losartan/hydrochlorothiazide for 'real world' management of isolated systolic hypertension.
Topics: Adult; Aged; Cross-Sectional Studies; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Retrospective Studies; Systole | 2015 |
An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney.
Topics: Albuminuria; Animals; Blood Pressure; Drug Combinations; Furosemide; Hydrochlorothiazide; Hypertension; Kidney; Losartan; Male; Rats; Rats, Wistar; Renal Circulation | 2016 |
Chlorothiazide-induced photoaggravation of psoriatic lesion during narrowband ultraviolet B treatment in a case of psoriasis vulgaris.
Topics: Aged; Disease Progression; Drug Combinations; Female; Ficusin; Humans; Hydrochlorothiazide; Hypertension; Losartan; Photochemotherapy; Psoriasis; Severity of Illness Index; Treatment Outcome; Ultraviolet Therapy | 2017 |
Losartan/hydrochlorothiazide combination is safe and effective for morning hypertension in Very-Elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney; Losartan; Male; Middle Aged; Potassium; Time Factors; Treatment Outcome | 2018 |
Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) Database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Female; Humans; Hydrochlorothiazide; Incidence; Japan; Ketoprofen; Losartan; Male; Middle Aged; Odds Ratio; Photosensitivity Disorders; Seasons; Sodium Chloride Symporter Inhibitors; Valsartan; Young Adult | 2017 |